Update on optimal use of lisdexamfetamine in the treatment of ADHD

Código QR

Update on optimal use of lisdexamfetamine in the treatment of ADHD

Vishal Madaan, Venkata Kolli, Durga P Bestha, Manan J ShahDepartment of Psychiatry and Neurobehavioral Sciences, Division of Child and Family Psychiatry, University of Virginia Health System, Charlottesville, VA, USAAbstract: Lisdexamfetamine (LDX) has been a recent addition to the treatment armamen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Madaan V, Kolli V, Bestha DP, Shah MJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/66d15f362b1b4855b3041aeb77e69530
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Diana Domnitei, et al.
Publicado: (2010)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan V, et al.
Publicado: (2011)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Michael Pennick
Publicado: (2010)

Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
por: Sharman J, et al.
Publicado: (2014)

Treatment of adult ADHD: Is current knowledge useful to clinicians?
por: Terje Torgersen, et al.
Publicado: (2008)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Brandon C Strange
Publicado: (2008)

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Joseph Biederman, et al.
Publicado: (2008)

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
por: Coghill DR, et al.
Publicado: (2014)

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
por: Ermer J, et al.
Publicado: (2013)

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
por: Weisler RH, et al.
Publicado: (2013)

Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents
por: Duric NS, et al.
Publicado: (2014)

Update on the role of antipsychotics in the treatment of Tourette syndrome
por: Huys D, et al.
Publicado: (2012)

Pregabalin for the treatment of generalized anxiety disorder: an update
por: Baldwin DS, et al.
Publicado: (2013)

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova AI, et al.
Publicado: (2016)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Update on treatment of partial onset epilepsy: role of eslicarbazepine
por: Markus Rauchenzauner, et al.
Publicado: (2010)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss M, et al.
Publicado: (2017)

Optimal management of ADHD in older adults
por: Torgersen T, et al.
Publicado: (2016)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
por: L&oacute;pez F, et al.
Publicado: (2011)

General versus executive cognitive ability in pupils with ADHD and with milder attention problems
por: Ek U, et al.
Publicado: (2013)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007)

Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline
por: Delgado Nunes V, et al.
Publicado: (2013)

Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment
por: Jos&eacute; F. Tellez-Zenteno, et al.
Publicado: (2008)

Reliability and Validity of the Chen ADHD Scale (C-ADHDS)
por: Chen YL, et al.
Publicado: (2021)

Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
por: Evangelia Stergiakouli, et al.
Publicado: (2010)

Effectiveness of a focused, brief psychoeducation program for parents of ADHD children: improvement of medication adherence and symptoms
por: Bai GN, et al.
Publicado: (2015)

Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study
por: Biederman J, et al.
Publicado: (2012)

Update on treatment options for Lambert&ndash;Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist S, et al.
Publicado: (2011)

The Multiple Sclerosis Treatment Optimization Program
por: Annette Langer‐Gould, et al.
Publicado: (2021)

Short cognitive behavioral therapy and cognitive training for adults with ADHD &ndash; a randomized controlled pilot study
por: Maarit Virta, et al.
Publicado: (2010)

Clinical utility of the Chinese Strengths and Weaknesses of ADHD-Symptoms and Normal-behaviors questionnaire (SWAN) when compared with DISC-IV
por: Chan GFC, et al.
Publicado: (2014)

Update on rufinamide in childhood epilepsy
por: Coppola G
Publicado: (2011)

Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
por: Maneeton N, et al.
Publicado: (2015)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Robert H Howland
Publicado: (2009)

The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies
por: Aagaard L, et al.
Publicado: (2011)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Ann M Mortimer
Publicado: (2009)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Optimal treatment of social phobia: systematic review and meta-analysis
por: Scott KM, et al.
Publicado: (2012)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)